Provided by Tiger Fintech (Singapore) Pte. Ltd.

Karyopharm Therapeutics

7.09
-0.2700-3.67%
Post-market: 7.360.2700+3.81%19:07 EDT
Volume:107.24K
Turnover:791.36K
Market Cap:60.76M
PE:-0.51
High:7.83
Open:7.20
Low:7.04
Close:7.36
Loading ...
Jun 05, 2024

Correspondence

Form CORRESP - Correspondence
May 31, 2024

Major Issues Report

Form 8-K - Current report
May 30, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 23, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Major Issues Report

Form 8-K - Current report
Apr 04, 2024

Correspondence

Form CORRESP - Correspondence
Feb 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 29, 2024

Major Issues Report

Form 8-K - Current report
Feb 20, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 13, 2023

Major Issues Report

Form 8-K - Current report
Dec 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]